ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
CKD-hyperparathyroidism, hyperphosphatemia, hyperkalemia market to grow at 6.9% CAGR by 2030: GlobalData
May 19, 2021Historically, the CKD-HPT, HP, and HK disease space mainly consisted of reformulations of existing drugs and repurposed drugs from other disease markets. -
HK researchers design neurosurgical robotic system
July 24, 2018According to the researchers, this innovation is expected to facilitate the treatment of Parkinson’s disease and other neuropsychiatric disorders. -
Suven gets patents from HK, India, US on neurological molecule
November 17, 2017Suven Life Sciences has been granted a patent each from Hong Kong, S.A.R., China and the US and two from India for treatment of disorders associated with neurodegenerative diseases.
Pharma Sources Insight January 2025
